ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,000 | -13.2% | 219,258 | 0.0% | 0.00% | – |
| Q2 2022 | $53,000 | -14.5% | 219,258 | 0.0% | 0.00% | – |
| Q1 2022 | $62,000 | -49.6% | 219,258 | 0.0% | 0.00% | – |
| Q4 2021 | $123,000 | -44.8% | 219,258 | 0.0% | 0.00% | – |
| Q3 2021 | $223,000 | -26.2% | 219,258 | 0.0% | 0.00% | – |
| Q2 2021 | $302,000 | -82.0% | 219,258 | -77.8% | 0.00% | – |
| Q1 2021 | $1,678,000 | +51.4% | 987,434 | +10.5% | 0.00% | – |
| Q4 2020 | $1,108,000 | -13.4% | 893,928 | -0.7% | 0.00% | – |
| Q3 2020 | $1,279,000 | +10.6% | 900,195 | -5.8% | 0.00% | – |
| Q2 2020 | $1,156,000 | -5.9% | 955,582 | -8.3% | 0.00% | – |
| Q1 2020 | $1,229,000 | -41.3% | 1,041,644 | +4.9% | 0.00% | – |
| Q4 2019 | $2,095,000 | -1.5% | 992,818 | +2.7% | 0.00% | -100.0% |
| Q3 2019 | $2,126,000 | +189.6% | 966,604 | +233.0% | 0.00% | – |
| Q2 2019 | $734,000 | +61.7% | 290,252 | +122.4% | 0.00% | – |
| Q1 2019 | $454,000 | +48.9% | 130,508 | -1.3% | 0.00% | – |
| Q4 2018 | $305,000 | -30.8% | 132,197 | +15.4% | 0.00% | – |
| Q3 2018 | $441,000 | +75.7% | 114,525 | +54.3% | 0.00% | – |
| Q2 2018 | $251,000 | +30.7% | 74,236 | -18.9% | 0.00% | – |
| Q1 2018 | $192,000 | +67.0% | 91,481 | +60.8% | 0.00% | – |
| Q4 2017 | $115,000 | -54.4% | 56,897 | +3.8% | 0.00% | – |
| Q3 2017 | $252,000 | +108.3% | 54,829 | -2.2% | 0.00% | – |
| Q2 2017 | $121,000 | -89.5% | 56,061 | -84.7% | 0.00% | – |
| Q1 2017 | $1,155,000 | +17.6% | 366,387 | -3.0% | 0.00% | – |
| Q4 2016 | $982,000 | -32.8% | 377,636 | +0.5% | 0.00% | – |
| Q3 2016 | $1,462,000 | +43.6% | 375,832 | -0.6% | 0.00% | – |
| Q2 2016 | $1,018,000 | +565.4% | 378,243 | +663.1% | 0.00% | – |
| Q1 2016 | $153,000 | -9.5% | 49,564 | +13.0% | 0.00% | – |
| Q4 2015 | $169,000 | +31.0% | 43,881 | +3.5% | 0.00% | – |
| Q3 2015 | $129,000 | -86.7% | 42,393 | -81.4% | 0.00% | – |
| Q2 2015 | $969,000 | -6.1% | 228,502 | -14.6% | 0.00% | – |
| Q1 2015 | $1,032,000 | -43.6% | 267,442 | -1.7% | 0.00% | -100.0% |
| Q4 2014 | $1,831,000 | +23.2% | 272,017 | +0.5% | 0.00% | – |
| Q3 2014 | $1,486,000 | -44.8% | 270,741 | +3.0% | 0.00% | -100.0% |
| Q2 2014 | $2,693,000 | -25.5% | 262,748 | -12.7% | 0.00% | 0.0% |
| Q1 2014 | $3,614,000 | -0.6% | 300,920 | -6.4% | 0.00% | 0.0% |
| Q4 2013 | $3,636,000 | +7.9% | 321,488 | +2.8% | 0.00% | 0.0% |
| Q3 2013 | $3,370,000 | +268.3% | 312,646 | +216.5% | 0.00% | – |
| Q2 2013 | $915,000 | – | 98,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |